Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24d41624f4c12622605b7048517fe8f7 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 |
filingDate |
2008-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c5605fbf2ebc167ccbca56059617624 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d78e1bc7190a6ec03c8a5c4185440318 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b97934c7840823a18cbba4bed4c9786a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b19648eff150b87af0202daa8aa09b7e |
publicationDate |
2009-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009117098-A1 |
titleOfInvention |
Complement C1Q Inhibitors For The Prevention And Treatment Of Glaucoma |
abstract |
The invention concerns in one embodiment a method of treating glaucoma or elevated intraocular pressure comprising administering a pharmaceutically effective amount of a composition comprising a Complement C1q inhibitor. In another embodiment, the invention concerns a composition for the treatment of elevated intraocular pressure and glaucoma, the composition comprising a pharmaceutically effective amount of a Complement C1q inhibitor. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018528169-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011112993-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018081250-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019137922-A1 |
priorityDate |
2007-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |